Six-month results from Phase I/II study indicate that RepliCel’s RCT-01 fibroblasts demonstrated product safety and clinical potential for tendon regeneration and healing.
Earlier this year, an ORTHOWORLD Member asked us: What portion of new products introduced in joint reconstruction and spine are additively manufactured? Here's what our analysis shows.
Study results indicate that percutaneous intramedullary fixation provided by IlluminOss Medical’s light curable monomer system can provide stabilization of fractures without open surgery.